Article Information
- Received June 4, 1999
- Revision received July 26, 1999
- Accepted August 2, 1999
- First published October 15, 1999.
- Version of record published October 15, 1999.
Author Information
Author contributions
Disclosures
- Received June 4, 1999.
- Revision received July 26, 1999.
- Accepted August 2, 1999.
This work was supported by Swiss National Science Foundation Grants 31-42299.94 and 31-45549.95 to C.E.B. and M.E.S., by the Maurice E. Müller Foundation (Berne), the Dr. Eric Slack-Gyr Foundation (Zürich), the Binelli-Ehrsam Foundation (Zürich), and grants from the Krebsliga des Kanton Zürich, the Lydia Hochstrasser Foundation, and the Swiss National Science Foundation to D.R.Z. We thank R. Schöb for assistance with the photomicrographs, Dr. Y. Yamaguchi for providing the anti-brevican, Dr. U. Rauch for providing the anti-neurocan antibody, and Dr. A. Faissner for providing the anti-tenascin antibodies.
Correspondence should be addressed to Dr. Christine Bandtlow, University of Zürich, Brain Research Institute, Winterthurerstrasse 190, 8057 Zürich, Switzerland.
Online Impact